Neuropsychopharmacology
- Reversible modulation of a deep white matter surgical target for depression with low-intensity focused ultrasound10 months ago
- There is still so much work to be done: a mother’s perspective10 months ago
- Fueling the future: brain bioenergetics as a driver of neurodevelopment and mental health trajectories10 months ago
- Optimizing social media initiatives to promote Neuropsychopharmacology (NPP) publications10 months ago
- Reply to Kim and Jeong: Namesake of PF-05231023: how nomenclature confusion leads to experimental misinterpretation in pharmacologic research10 months ago
- Moving from isolation to integration: a Bayesian multisensory perspective of interoception and psychosis10 months ago
- Carvone derived cannabidiol enantiomers as novel anticonvulsants10 months ago
Journal of Psychopharmacology
- Exploring the effects of erythropoietin treatment on cortical thickness and hippocampal volume in patients with mood disorders undergoing electroconvulsive therapy: A randomized, placebo-controlled trial2 years ago
- Ketamine for treatment-resistant obsessive-compulsive disorder: Double-blind active-controlled crossover study2 years ago
- Repurposing of erythropoietin as a neuroprotective agent against methotrexate-induced neurotoxicity in rats2 years ago
- Promising strategies for the prevention of alcohol-related brain damage through optimised management of acute alcohol withdrawal: A focussed literature review2 years ago
- Responses to clinical treatment of bipolar versus unipolar depressive episodes in women versus men2 years ago
- Benzodiazepines for PTSD: Poor data quality and misleading advice2 years ago
- Psilocybin for major depressive disorder: An updated systematic review and meta-analysis of randomized clinical trials2 years ago
European Neuropsychopharmacology
- Does 18 Hz deep TMS benefit a different subgroup of depressed patients relative to 10 Hz rTMS? The role of the individual alpha frequency2 years ago
- The post COVID era in mental health systems: Better together2 years ago
- Towards a consensus roadmap for a new diagnostic framework for mental disorders2 years ago
- Collaborative outcomes study on health and functioning during infection times (COH-FIT): Insights on modifiable and non-modifiable risk and protective factors for wellbeing and mental health during the COVID-19 pandemic from multivariable and network analyses2 years ago
- Structural connectivity of dopaminergic pathways in major depressive disorder: An ultra-high resolution 7-Tesla diffusion MRI study2 years ago
- A higher desmethylclomipramine to clomipramine ratio predicts more effectiveness and fewer adverse effects in major depressive disorder2 years ago
- Lung function decline in people with serious mental illness: A call to action2 years ago